Gastroenterology
Volume 134, Issue 5 , Pages 1385-1395.e1, May 2008

Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41

This study was presented at the American Association for the Study of Liver Disease meeting in Boston, October 29-November 2, 2004, and at the 40th Annual Meeting of the European Association for the Study of the Liver, in Paris, April 13-17, 2005.

  • Christoph S. Klade

      Affiliations

    • Intercell AG, Vienna, Austria
  • ,
  • Heiner Wedemeyer

      Affiliations

    • Medical School Hannover, Hannover, Germany
  • ,
  • Thomas Berg

      Affiliations

    • University Clinic Charité, Berlin, Germany
  • ,
  • Holger Hinrichsen

      Affiliations

    • University Clinic Schleswig-Holstein, Kiel, Germany
  • ,
  • Grazyna Cholewinska

      Affiliations

    • Wojewodzky Hospital Zakazny, Warshaw, Poland
  • ,
  • Stefan Zeuzem

      Affiliations

    • University Clinic, Homburg/Saar, Germany
  • ,
  • Hubert Blum

      Affiliations

    • Medical University Clinic, Freiburg, Germany
  • ,
  • Michael Buschle

      Affiliations

    • Intercell AG, Vienna, Austria
  • ,
  • Sandra Jelovcan

      Affiliations

    • Intercell AG, Vienna, Austria
  • ,
  • Vera Buerger

      Affiliations

    • Intercell AG, Vienna, Austria
  • ,
  • Erich Tauber

      Affiliations

    • Intercell AG, Vienna, Austria
  • ,
  • Juergen Frisch

      Affiliations

    • Intercell AG, Vienna, Austria
  • ,
  • Michael P. Manns

      Affiliations

    • Medical School Hannover, Hannover, Germany
    • Corresponding Author InformationAddress requests for reprints to: Michael P. Manns, MD, Prof, Medizinische Hochschule Hannover, Abt. Gastroenterologie, Hepatologie und Endokrinologie, Carl-Neuberg Str. 1, 30625 Hannover, Germany. fax: (49) 511 532 4896.

Received 28 September 2006; accepted 24 January 2008. published online 28 February 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Conflicts of interest: C.S.K. is an employee of Intercell AG. H.W., M.P.M., H.B., H.H., T.B., and S.Z. have received consultancy fees from Intercell AG.

 C.K.L. and H.W. contributed equally to this work.

 Supported by research grants from Intercell AG (to H.W., T.B., H.H., G.C., S.Z., and H.B.) and by a generous grant from the Austrian Fond zur Förderung der Forschung (FFG).

PII: S0016-5085(08)00346-6

doi:10.1053/j.gastro.2008.02.058

Refers to article:

  • Therapeutic Vaccination for Hepatitis C: Can Protective T-Cell Responses Be Restored After Prolonged Antigen Exposure?

    Carlo Ferrari
    Gastroenterology May 2008 (Vol. 134, Issue 5, Pages 1601-1604)

Gastroenterology
Volume 134, Issue 5 , Pages 1385-1395.e1, May 2008